Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - EnVivo

  • Seeking New Tools Against Alzheimer's
    Adamas is carrying out the U.S. trial with Forest Labs. EnVivo Pharmaceuticals has said it will launch this year a Phase III trial of alpha-7 agonist EVP-6124, after releasing ...
    6-7-2013
  • People in the News
    ... its scientific advisory board...Organovo appointed Eric Michael David, M.D., J.D. , as CSO...EnVivo Pharmaceuticals added Alfred Sandrock, M.D., Ph.D. , to its board of directors. ...
    7-1-2012
  • People in the News
    Antoun Nabhan, J.D. , joined Tobira Therapeutics as vp, business development. Christopher L. Burnley EnVivo Pharmaceuticals named Christopher L. Burnley as CBO. Burnley was a ...
    5-15-2012
  • Mitsubishi Tanabe Gains Asian Rights to EnVivo's Cognition-Enhancing...
    Mitsubishi Tanabe Pharma (MTPC) licensed EnVivo Pharmaceuticals' cognition-enhancing ... EnVivo will also receive royalties on sales of EVP-6124 in the MTPC territory, which ...
    4-1-2009
  • Waging a Multipronged Alzheimer's War
    ... several young companies that have active discovery programs for AD. These included Allon Therapeutics, TauRx, Accera, EnVivo Pharmaceuticals, NeuroNascent, and Sanomune. ...
    11-1-2008
  • MethylGene and Envivo Receive $1.5M to Advance Huntington's Disease...
    MethylGene and EnVivo Pharmaceuticals entered into a collaborative agreement with CHDI, a ... MethylGene and EnVivo formed a collaboration in February, 2005 focused on MethylGene's ...
    11-16-2006

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll